Related Experiment Video

Updated: May 26, 2026

Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction
09:44

Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction

Published on: January 29, 2019

Targeting 14-3-3zeta in cancer therapy

X Yang1, W Cao, L Zhang

  • 1Institute of Neurosurgery, Xijing Hospital, Fourth Military Medical University, Xi'an, Shaanxi Province, People's Republic of China.

Cancer Gene Therapy
|December 24, 2011
PubMed

Insights

The 14-3-3zeta protein suppresses apoptosis and drives cancer growth. Targeting 14-3-3zeta offers a promising new strategy for developing effective gene therapy and anticancer interventions against various tumors.

Area of Science:

  • Oncology
  • Molecular Biology
  • Gene Therapy

Background:

  • 14-3-3zeta, a protein family member, inhibits apoptosis.
  • It plays a key role in tumor initiation and advancement.
  • 14-3-3zeta is frequently overexpressed in human cancers.

Purpose of the Study:

  • To review the multifaceted role of 14-3-3zeta in cancer development.
  • To explore 14-3-3zeta as a potential therapeutic target for novel anticancer strategies.

Main Methods:

  • Literature review focusing on 14-3-3zeta's function in tumorigenesis.
  • Analysis of 14-3-3zeta's involvement in cancer progression and therapeutic resistance.

Main Results:

  • 14-3-3zeta's upregulation correlates with tumor progression.
  • Its inhibition of apoptosis contributes to cancer survival.
  • 14-3-3zeta is implicated in resistance to cancer treatments.

Conclusions:

  • 14-3-3zeta is a significant factor in cancer genesis and progression.
  • Targeting 14-3-3zeta presents a viable therapeutic avenue for cancer treatment.
  • Further investigation into 14-3-3zeta-based therapies is warranted.

More Related Videos

Expansion of Human Peripheral Blood γδ T Cells using Zoledronate13:08

Expansion of Human Peripheral Blood γδ T Cells using Zoledronate

Published on: September 9, 2011

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...